Phreesia, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Phreesia, Inc. on August 13, 2020. The company is an emerging growth company incorporated in Delaware, with its common stock trading on the New York Stock Exchange under the symbol PHR. The filing primarily addresses a Regulation FD disclosure regarding a research paper published on the same date.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses on a non-financial disclosure event rather than periodic financial results.
Material Changes
No material changes to financial performance or operational status are reported in this document. The significant event is the publication of a research paper co-authored by Phreesia, Harvard University, and The Commonwealth Fund. The paper analyzes changes in visit volume for over 50,000 providers who are Phreesia clients.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management outlook, or specific risk factors. It notes that the information regarding the research paper (Exhibit 99.1) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 to understand the specific findings regarding provider visit volume changes.
- Verify the methodology used in the research paper co-authored by Phreesia, Harvard University, and The Commonwealth Fund.
- Check subsequent filings for any financial impact resulting from the trends identified in the research paper.
- Confirm that the research paper is not incorporated by reference in other regulatory documents unless explicitly stated.